González-Romero N, Lobato-Izagirre A, Blanch-Rius L, Cancho-Galán G, Izu-Belloso R

Language: Spanish
References: 13
Page: 63-68
PDF size: 201.20 Kb.

ABSTRACT

Introduction: Merkel cell carcinoma (MCC) is a rare cutaneous neoplasm with a poor prognosis. There is no consensus to address its management. Material and methods: We performed a search of patients with histological diagnosis of MCC from 1998 to 2018 (n = 20), in the database of our hospital and we collected next data: sex, age, history of immunosuppression, skin cancer no melanoma and malignant melanoma, initial diagnosis suspicion, tumor size, location, staging, treatments received, evolution and survival. Results: The majority of lesions (40%) were located in the face and neck and 50% had 2 to 5 cm. 85% of the patients received surgical treatment, 75% had RT. 50% of patients had recurrence, all before the first 24 months. In our sample, we observed that survival is greater in patients with lesions smaller than 2 cm, located in extremities, positive for polyomavirus, in those who have received adjuvant RT and in those without affected surgical. Conclusions: We have observed five factors associated with grater survival, which, although not statistically significant, are clinically relevant and concur with those of other series.

REFERENCES

1. Llombart B, Requena C, Cruz J. Update on Merkel cell carcinoma: epidemiology, etiopathogenesis, clinical features, diagnosis, and staging. Actas Dermosifiliogr. 2017; 108 (2): 108-119.

2. Santos-Juanes J, Fernández-Vega I, Fuentes N, Galache C, Coto-Segura P, Vivanco B et al. Merkel cell carcinoma and Merkel cell polyomavirus: a systematic review and meta-analysis. Br J Dermatol. 2015; 173 (1): 42-49.

3. Llombart B, Kindem S, Chust M. Merkel cell carcinoma: an update of key imaging techniques, prognostic factors, treatment, and follow-up. Actas Dermosifiliogr. 2017; 108 (2): 98-107.

4. Tello TL, Coggshall K, Yom SS, Yu SS. Merkel cell carcinoma: An update and review: Current and future therapy. J Am Acad Dermatol. 2018; 78 (3): 445-454.

5. Gunaratne DA, Howle JR, Veness MJ. Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases. Br J Dermatol. 2016; 174 (2): 273-281.

6. Bommareddy PK, Kaufman HL. Avelumab and other recent advances in Merkel cell carcinoma. Future Oncol. 2017; 13 (30): 2771-2783.

7. Ruiz R, Blasco J, Merino J, Linares J, Naranjo R. Carcinoma de células de Merkel. Presentación de 6 casos. Actas Dermosifiliogr. 2003; 94: 300-304.

8. Llombart B, Monteagudo C, López-Guerrero JA, Carda C, Jorda E, Sanmartín O et al. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology. 2005; 46 (6): 622-634.

9. Dañino-García M, Domínguez-Cruz JJ, Pérez-Ruiz C, Conejo-Mir J, Pereyra-Rodríguez JJ. Clinical and epidemiological characteristics of Merkel cell carcinoma in a series of 38 patients. Actas Dermosifiliogr. 2019; 110 (5): 360-365.

10. Iyer JG, Storer BE, Paulson KG, Lemos B, Philips JL, Bichakjian CK et al. Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma. J Am Acad Dermatol. 2014; 70 (4): 637-643.

11. Gollard R, Weber R, Kosty MP, Greenway HT, Massullo V, Humberson C. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer. 2000; 88: 1842-1851.

12. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005; 23: 2300-2309.

13. Bhatia S, Storer BE, Iyer JG, Moshiri A, Parvathaneni U, Byrd D et al. Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: survival analyses of 6908 cases from the National Cancer Data Base. J Natl Cancer Inst. 2016; 108 (9). pii: djw042.